Τρίτη 5 Μαΐου 2020

A gene expression-based immune signature for lung adenocarcinoma prognosis
Abstract Background Lung adenocarcinoma (LUAD) has become the most frequent histologic type of lung cancer in the past several decades. Recent successes with immune checkpoint blockade therapy have demonstrated that the manipulation of the immune system is a very potent treatment for LUAD. This study aims to explore the role of immune-related genes in the development of LUAD and establish a signature that can predict overall survival...
Cancer Immunology, Immunotherapy
Tue May 05, 2020 03:00
Cysteine cathepsins L and X differentially modulate interactions between myeloid-derived suppressor cells and tumor cells
Abstract Increased proteolytic activity of cysteine cathepsins has long been known to facilitate malignant progression, and it has also been associated with tumor-promoting roles of myeloid-derived suppressor cells (MDSCs). Consequently, cysteine cathepsins have gained much attention as potential targets for cancer therapies. However, cross-talk between tumor cells and MDSCs needs to be taken into account when studying the efficacy of cathepsin inhibitors as anti-cancer agents....
Cancer Immunology, Immunotherapy
Tue May 05, 2020 03:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου